Publications by authors named "Eva Barragan"

72Publications

Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants.

Hematol Oncol Stem Cell Ther 2020 May 20. Epub 2020 May 20.

Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2020.05.007DOI Listing
May 2020

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single Fusion Gene.

Cancers (Basel) 2020 Mar 8;12(3). Epub 2020 Mar 8.

Department of Hematology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12030624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139833PMC
March 2020

Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?

Blood Rev 2020 Nov 2;44:100675. Epub 2020 Mar 2.

Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell, 106, 46026 Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100675DOI Listing
November 2020

-mutated relapsed or refractory AML: current challenges and future prospects.

Blood Lymphat Cancer 2019 27;9:19-32. Epub 2019 Jun 27.

Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S177913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663038PMC
June 2019

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.

J Mol Diagn 2019 03 19;21(2):228-240. Epub 2018 Dec 19.

Molecular Biology Unit, Clinical Pathology Service, La Fe University and Polytechnic Hospital, Valencia, Spain; La Fe Health Research Institute, Hematology Research Group, Valencia, Spain; CIBERONC, Carlos III Health Research Institute, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.09.009DOI Listing
March 2019

Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia.

Leuk Lymphoma 2016 Feb 19;57(2):429-435. Epub 2015 Jun 19.

a Department of Medical Pathology , Hospital Universitario y Politécnico La Fe , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1049167DOI Listing
February 2016

α-Thalassemia does not seem to influence erythrocyte deformability in sickle cell trait carriers.

Hemoglobin 2014 7;38(3):165-8. Epub 2014 Mar 7.

Haemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital , Valencia , Spain .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/03630269.2014.888353DOI Listing
February 2015

Erythrocyte deformability and aggregation in homozygous sickle cell disease.

Clin Hemorheol Microcirc 2014 ;58(4):497-505

Molecular Biology Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CH-131717DOI Listing
September 2015

The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.

Fam Cancer 2013 Mar;12(1):119-23

Laboratorio de Biología Molecular, Escuela de Enfermería 7ª planta, Hospital Universitario La Fe, Avd. Campanar 21, 46009, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-012-9579-6DOI Listing
March 2013

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.

Ann Hematol 2012 Jan 3;91(1):1-7. Epub 2011 May 3.

Laboratory of Molecular Biology, Department of Medical Pathology, Hospital Universitario La Fe, Escuela de enfermería 7ª planta., Avd. Campanar 21, Valencia 46009, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-011-1234-zDOI Listing
January 2012

Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.

J Mol Diagn 2009 Sep 30;11(5):458-63. Epub 2009 Jul 30.

Laboratory of Molecular Biology, Department of Medical Pathology, Escuela de enfermería 7 planta. Hospital Universitario La Fe, Avd. Campanar 21, Valencia 46009, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152515781060264
Publisher Site
http://dx.doi.org/10.2353/jmoldx.2009.090043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729844PMC
September 2009

Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.

Clin Chim Acta 2008 Sep 8;395(1-2):120-3. Epub 2008 Jun 8.

Department of Medical Pathology, Hospital Universitario La Fe Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2008.05.021DOI Listing
September 2008

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.

Breast Cancer Res Treat 2009 May 5;115(2):405-14. Epub 2008 Jun 5.

Laboratory of Molecular Biology, University Hospital La Fe, Avd. Campanar 21, Valencia 46009, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-008-0073-7
Publisher Site
http://dx.doi.org/10.1007/s10549-008-0073-7DOI Listing
May 2009

MLL amplification in acute myeloid leukemia.

Cancer Genet Cytogenet 2007 Apr;174(2):127-31

Servicio de Hematología, Hospital Universitario La Fe, Avenida Campanar 21, Valencia 46009, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2006.11.019DOI Listing
April 2007

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.

Br J Haematol 2007 Feb;136(4):590-6

Laboratory of Molecular Biology (Medical Biopathology), Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06469.xDOI Listing
February 2007

The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.

Haematologica 2007 Mar;92(3):308-14

Laboratory of Molecular Biology, Department of Medical Biopathology, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.10752DOI Listing
March 2007

Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.

Leuk Res 2006 Dec 4;30(12):1471-91. Epub 2006 Oct 4.

Laboratory of Molecular Biology, Department of Medical Biopathology, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.01.016DOI Listing
December 2006

A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.

Cancer Genet Cytogenet 2006 Jul;168(1):73-6

Department of Hematology, Hospital Universitario La Fe, Avenida Campanar, 21, 46009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2005.12.014DOI Listing
July 2006

Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis.

Clin Chim Acta 2006 Jun 9;368(1-2):195-8. Epub 2006 Feb 9.

Molecular Biology Laboratory, Department of Medical Biopathology Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2005.12.041DOI Listing
June 2006

[BRCA1 and BRCA2 mutations in patients with familial breast cancer].

Med Clin (Barc) 2005 Jan;124(1):10-2

Laboratorio de Biología Molecular, Departamento de Biopatología Médica, Escuela de Enfermeria, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1157/13070435DOI Listing
January 2005

Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies.

Clin Chem 2004 Nov;50(11):2201-4

Laboratory of Molecular Biology, Department of Medical Biopathology, Clinical Hematology, Service of Hematology, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2004.038331DOI Listing
November 2004

Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.

Haematologica 2004 Aug;89(8):926-33

Molecular Biology Laboratory, Dept. Medical Biopathology, Hematology Service of Hospital Universitario La Fe. Hematology Services of Hospital General Universitario Alicante, Spain.

View Article

Download full-text PDF

Source
August 2004

Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.

Haematologica 2003 Jan;88(1):19-24

Molecular Biology Laboratory (Dept. Medical Pathology), Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
January 2003

Rapid detection of the major Mediterranean beta-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes.

Br J Haematol 2002 Nov;119(2):554-7

Laboratorio de Biología Molecular, Dpto. Biopatología Clínica, Hospital Universitario La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03823.xDOI Listing
November 2002

Identification of two atypical PML-RAR(alpha) transcripts in two patients with acute promyelocytic leukemia.

Leuk Res 2002 May;26(5):439-42

Laboratory of Molecular Biology, Department of Clinical Pathology, Centro Maternal, Hospital Universitario La Fe, Avda Campanar 21, 46009 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(01)00158-8DOI Listing
May 2002